Solid Biosciences (SLDB) Asset Utilization Ratio (2021 - 2023)
Solid Biosciences (SLDB) reported Asset Utilization Ratio of 0.03 for Q1 2023, down 54.62% on a YoY basis from 0.06 in Q1 2022, and down 30.8% sequentially from 0.04 in Q4 2022.
Solid Biosciences (SLDB) Asset Utilization Ratio (2021 - 2023) Analysis & Trends
Solid Biosciences (SLDB) has 3 years of Asset Utilization Ratio data on file, last reported at 0.03 in Q1 2023.
- For the quarter ending Q1 2023, Asset Utilization Ratio fell 54.62% year-over-year to 0.03; the trailing twelve-month figure through Mar 2023 stood at 0.03 (down 54.62% YoY), and the FY2022 full-year result was 0.03, down 51.32% from the prior year.
- Asset Utilization Ratio declined to 0.03 in Q1 2023, from 0.04 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.07 in Q2 2022 to a low of 0.01 in Q1 2021.
- A 3-year average of 0.04 and a median of 0.04 in 2021 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio jumped 279.86% in 2022 and slumped 54.62% in 2023, its largest moves.
- Tracing SLDB's Asset Utilization Ratio over 3 years: stood at 0.06 in 2021, then plunged by 35.68% to 0.04 in 2022, then tumbled by 30.8% to 0.03 in 2023.
- Business Quant data shows SLDB's Asset Utilization Ratio at 0.03 in Q1 2023, 0.04 in Q4 2022, and 0.06 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Solid Biosciences | 529.40 Mn | 529.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.07 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.04 |
| Jun 30, 2021 | 0.03 |
| Mar 31, 2021 | 0.01 |